InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (22 ops.)
Insider track record
OtherDisclosed buys
5
Disclosed sells
22
T+90 hit rate
0%
T+90 mean return
-42.5%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Novo Holdings A/S. Officer active across 14 companies, notably Spruce Biosciences, INC.. Cumulatively, 38 filings have been recorded. Breakdown: 5 buys · 22 sells. Total volume traded: €162.7m. History available since 19 May 2021. The latest transaction was disclosed on 1 May 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations38 total
3,327,734 sharesVoting Common StockSEC:0001388325-26-000021:0
555,555 shares@ US$18.00100.0% of flowVoting Common StockSEC:0001388325-26-000021:1
Ideal exit: 26 Jan 2027 (T+270)
51,522 shares@ US$1.32641.0% of flowCOMMON STOCKSEC:0000950170-24-087061:0
658,809 shares@ US$1.218111.9% of flowCOMMON STOCKSEC:0000950170-24-059965:0
465,021 shares@ US$0.75471.6% of flowCOMMON STOCKSEC:0001209191-24-005075:0
842,020 shares@ US$0.76843.0% of flowCOMMON STOCKSEC:0001209191-24-005017:0
1,912,316 shares@ US$0.88847.8% of flowCOMMON STOCKSEC:0001209191-24-004900:0
100,000 shares@ US$10.25100.0% of flowCOMMON STOCKSEC:0001209191-24-003423:0
Ideal exit: 5 Nov 2024 (T+270)
658,809 shares@ US$1.500314.6% of flowCOMMON STOCKSEC:0001209191-24-003303:0
2,469,135 shares@ US$2.02572.5% of flowCommon StockSEC:0001209191-23-045444:0
Ideal exit: 5 May 2024 (T+270)
1,900 shares@ US$2.76160.1% of flowCommon StockSEC:0001209191-23-042977:0
11,000 shares@ US$2.73650.8% of flowCommon StockSEC:0001209191-23-042670:0
200,937 shares@ US$2.634115.2% of flowCommon StockSEC:0001209191-23-040691:0
1,250,000 shares@ US$46.10100.0% of flowCommon StockSEC:0001209191-23-040057:0
8,437 shares@ US$1.79050.4% of flowCommon StockSEC:0001209191-23-040129:0
4,834 shares@ US$1.99440.3% of flowCommon StockSEC:0001209191-23-039545:0
100,000 shares@ US$7.0974100.0% of flowCommon StockSEC:0001209191-23-039541:0
10,002 shares@ US$2.030.6% of flowCommon StockSEC:0001209191-23-038567:0
900 shares@ US$2.06450.1% of flowCommon StockSEC:0001209191-23-037208:0
2,208,000 shares@ US$3.1733.0% of flowCOMMON STOCKSEC:0001209191-23-011156:0
Ideal exit: 13 Nov 2023 (T+270)
484,496 shares@ US$10.32100.0% of flowCOMMON STOCKSEC:0001209191-22-050258:0
Ideal exit: 11 Jun 2023 (T+270)
900,000 shares@ US$3.0082.5% of flowCOMMON STOCKSEC:0001209191-22-043049:0
800,000 shares@ US$2.00100.0% of flowCOMMON STOCKSEC:0001209191-22-042241:0
1,820 shares@ US$2.8997100.0% of flowCommon StockSEC:0001209191-22-013316:0
3,183,545 sharesCOMMON STOCKSEC:0001209191-22-008145
25 of 38 declarations
About Novo Holdings A/S
Novo Holdings A/S is a significant shareholder in SPRUCE BIOSCIENCES, INC.
